For over 20 years, I’ve helped dozens of cancer patients understand their disease, navigate 2nd opinions, get critical biomarker testing, find clinical trials, and ask technical questions. I’ve helped my immediate family, friends of friends, co-workers, and total strangers.  In this time, I learned that one of the greatest unmet needs for patients is understanding and receiving biomarker testing of their tumors.

With ever-increasing complexity of the science, technology, and innovation in oncology, patients are not getting the individual support they need to ask for and understand cancer biomarker testing, results, and their implications.  In other words, they are not being empowered to know everything they can about their own disease and its treatment.

My work in cancer has spanned academic, non-profit, big pharma, and healthcare technology industries. I believe my unique educational, career, and personal experiences have led me to my true purpose of helping patients, 1-on-1, understand the complex biology of their specific cancers. 

I lost my only sister to a rare brain tumor.  She was 45. This tumor type wasn’t classified yet when she was diagnosed. Decades later, researchers found that even this extremely rare brain tumor type could be further divided into biomarker-specific categories that may now influence how it should be treated.

I dedicate my work not only to the memory of my sister, but to those who don’t understand or feel empowered to ask for biomarker testing which could radically, positively alter their treatment outcomes.

Kimary Kulig